{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T01:58:26Z","timestamp":1785376706281,"version":"3.55.0"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>The objective of our study was to characterize early-stage dementia with Lewy bodies (DLB) focusing on motor and non-motor symptoms.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This cross-sectional study prospectively included newly diagnosed DLB patients within 3\u202fyears of cognitive symptom onset. Comparisons were made with individuals with Parkinson\u2019s disease (PD), Alzheimer\u2019s disease (AD), and controls. Demographic and clinical data were collected, and motor and non-motor symptoms were assessed using structured interviews and validated scales and questionnaires.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 107 participants were included (23 DLB, 27 PD, 26 AD, and 31 controls). DLB patients (median age 75\u202fyears, median disease duration since diagnosis 2\u202fmonths) commonly reported motor symptoms, including gait disturbances (91.3%), tremor (73.9%), and bradykinesia (87%), with tremor being predominantly unilateral (76.5%) and action-type (52.9%). The most frequent motor subtype was akinetic-rigid (52.2%). Motor symptoms were similar to PD, except for more frequent falls (34.8% vs. 11.1%, <jats:italic>p<\/jats:italic>\u202f=\u202f0.044) and gait disturbances in DLB patients (91.3% vs. 63%, <jats:italic>p<\/jats:italic>\u202f=\u202f0.019). Non-motor symptoms, particularly visual hallucinations and neuropsychiatric symptoms were more prevalent in DLB than in PD, while sleep and autonomic symptoms were similar. An abnormal orthostatic test was more frequent in DLB than in PD (45.5% vs. 11.5%, <jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.008). Compared to AD, all non-motor symptoms were significantly more frequent in DLB. Finally, DLB patients had lower functional independence and quality of life than both PD and AD (<jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.0001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Early-stage DLB closely resembles PD in motor symptoms but has more neuropsychiatric non-motor symptoms compared to PD and overall non-motor symptoms than AD.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2025.1555175","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T05:22:21Z","timestamp":1741843341000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Key motor and non-motor features in early dementia with Lewy bodies"],"prefix":"10.3389","volume":"16","author":[{"given":"Anna","family":"Planas-Ballv\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Rios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"Ispierto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireia","family":"Gea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laia","family":"Grau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"C\u00e1ceres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00edlvia","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramiro","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pau","family":"Pastor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolores","family":"Vilas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1017\/S0033291713000494","article-title":"The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies","volume":"44","author":"Vann Jones","year":"2014","journal-title":"Psychol Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1017\/cjn.2016.2","article-title":"The prevalence and incidence of dementia with Lewy bodies: a systematic review","volume":"43","author":"Hogan","year":"2016","journal-title":"Can J Neurol Sci"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the global burden of disease study 2019","volume":"7","year":"2022","journal-title":"Lancet Public Health"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s40120-019-00154-7","article-title":"Burden of disease and current management of dementia with Lewy bodies: a literature review","volume":"8","author":"Tahami Monfared","year":"2019","journal-title":"Neurol Ther"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1080\/03007995.2022.2059978","article-title":"Epidemiology and economic burden of Lewy body dementia in the United States","volume":"38","author":"Desai","year":"2022","journal-title":"Curr Med Res Opin"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1002\/alz.13105","article-title":"Research diagnostic criteria for mild cognitive impairment with Lewy bodies: a systematic review and meta-analysis","volume":"19","author":"Donaghy","year":"2023","journal-title":"Alzheimers Dement"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1212\/WNL.0000000000009323","article-title":"Research criteria for the diagnosis of prodromal dementia with Lewy bodies","volume":"94","author":"McKeith","year":"2020","journal-title":"Neurology"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1136\/jnnp-2017-316385","article-title":"Cerebrospinal fluid Alzheimer biomarkers can be useful for discriminating dementia with Lewy bodies from Alzheimer's disease at the prodromal stage","volume":"89","author":"Bousiges","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13195-022-01037-0","article-title":"Prodromal characteristics of dementia with Lewy bodies: baseline results of the MEMENTO memory clinics nationwide cohort","volume":"14","author":"Blanc","year":"2022","journal-title":"Alzheimers Res Ther"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1024995","DOI":"10.3389\/fneur.2022.1024995","article-title":"Characteristics of initial symptoms in patients with dementia with Lewy body disease","volume":"13","author":"Fei","year":"2022","journal-title":"Front Neurol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/alz.12411","article-title":"The temporal onset of the core features in dementia with Lewy bodies","volume":"18","author":"Choudhury","year":"2022","journal-title":"Alzheimers Dement"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13195-021-00792-w","article-title":"Characterization of symptoms and determinants of disease burden in dementia with Lewy bodies: DEvELOP design and baseline results","volume":"13","author":"van de Beek","year":"2021","journal-title":"Alzheimers Res Ther"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"120815","DOI":"10.1016\/j.jns.2023.120815","article-title":"Clinical characteristics of pathological confirmed prodromal dementia with Lewy bodies","volume":"453","author":"Ting","year":"2023","journal-title":"J Neurol Sci"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1093\/brain\/awz111","article-title":"Evolution of prodromal Parkinson's disease and dementia with Lewy bodies: a prospective study","volume":"142","author":"Fereshtehnejad","year":"2019","journal-title":"Brain"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1176\/ajp.139.9.1136","article-title":"The global deterioration scale for assessment of primary degenerative dementia","volume":"139","author":"Reisberg","year":"1982","journal-title":"Am J Psychiatry"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement Disorder Society-sponsored revision of the unified Parkinson\u2019s disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1212\/wnl.17.5.427","article-title":"Parkinsonism: onset, progression and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/mds.25383","article-title":"How to identify tremor dominant and postural instability\/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the unified Parkinson's disease rating scale","volume":"28","author":"Stebbins","year":"2013","journal-title":"Mov Disord"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1002\/mds.20844","article-title":"International multicenter pilot study of the first comprehensive self completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study","volume":"21","author":"Chaudhuri","year":"2006","journal-title":"Mov Disord"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/mds.25037","article-title":"A single-question screen for rapid eye movement sleep behavior disorder: a multicenter validation study","volume":"27","author":"Postuma","year":"2012","journal-title":"Mov Disord"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A new method for measuring daytime sleepiness: the Epworth sleepiness scale","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1002\/mds.20153","article-title":"Assessment of autonomic dysfunction in Parkinson\u2019s disease: the Scopa-Aut","volume":"19","author":"Visser","year":"2004","journal-title":"Mov Disord"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1212\/wnl.44.12.2308","article-title":"The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1212\/wnl.62.2.181","article-title":"DLB fluctuations: specific features that reliably differentiate DLB from AD and normal aging","volume":"62","author":"Ferman","year":"2004","journal-title":"Neurology"},{"key":"ref29","first-page":"767","article-title":"Revalidation and standardization of the cognition mini-exam (first Spanish version of the mini-mental status examination) in the general geriatric population","volume":"112","author":"Lobo","year":"1999","journal-title":"Med Clin (Barc)"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"ref31","first-page":"79","article-title":"The Spanish version of EuroQol: a description and its applications","volume":"112","author":"Badia","year":"1999","journal-title":"Med Clin (Barc)"},{"key":"ref32","first-page":"152","volume-title":"Third symposium on Parkinson\u2019s disease","author":"Schwab","year":"1969"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1177\/08919887211023586","article-title":"Prodromal dementia with Lewy bodies: evolution of symptoms and predictors of dementia onset","volume":"35","author":"Wyman-Chick","year":"2022","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1111\/ene.15783","article-title":"Clinical symptoms in mild cognitive impairment with Lewy bodies: frequency, time of onset, and discriminant ability","volume":"30","author":"Donaghy","year":"2023","journal-title":"Eur J Neurol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3233\/JAD-150952","article-title":"Different clinical and neuroimaging characteristics in early stage Parkinson's disease with dementia and dementia with Lewy bodies","volume":"52","author":"Takemoto","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/ana.26670","article-title":"A comparison between early presentation of dementia with Lewy bodies, Alzheimer's disease, and Parkinson's disease: evidence from routine primary care and UK biobank data","volume":"94","author":"Nedelec","year":"2023","journal-title":"Ann Neurol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gaitpost.2016.08.009","article-title":"Motor performance differentiates individuals with Lewy body dementia, Parkinson's and Alzheimer's disease","volume":"50","author":"Fritz","year":"2016","journal-title":"Gait Posture"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12916-018-1016-8","article-title":"Are dementia with Lewy bodies and Parkinson\u2019s disease dementia the same disease?","volume":"16","author":"Jellinger","year":"2018","journal-title":"BMC Med"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.3233\/JPD-240174","article-title":"Parkinson's disease and dementia with Lewy bodies: one and the same?","volume":"14","author":"Jellinger","year":"2024","journal-title":"J Parkinsons Dis"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3233\/JPD-240002","article-title":"Parkinson's disease and dementia with Lewy bodies: one and the same","volume":"14","author":"Borghammer","year":"2024","journal-title":"J Parkinsons Dis"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1177\/0891988704267470","article-title":"Are Parkinson's disease with dementia and dementia with Lewy bodies the same entity?","volume":"17","author":"Aarsland","year":"2004","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/gps.389","article-title":"A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia","volume":"16","author":"Aarsland","year":"2001","journal-title":"Int J Geriatr Psychiatry"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1212\/WNL.0b013e31822c9148","article-title":"Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies","volume":"77","author":"Ferman","year":"2011","journal-title":"Neurology"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s00415-008-0629-9","article-title":"Is REM sleep behaviour disorder (RBD) a risk factor of dementia in idiopathic Parkinson's disease?","volume":"255","author":"Marion","year":"2008","journal-title":"J Neurol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1002\/mds.29590","article-title":"What's in a name? The time has come to unify Parkinson's disease and dementia with Lewy bodies","volume":"38","author":"Weintraub","year":"2023","journal-title":"Mov Disord"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1002\/mds.26796","article-title":"Abolishing the 1-year rule: how much evidence will be enough?","volume":"31","author":"Postuma","year":"2016","journal-title":"Mov Disord"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00401-020-02160-8","article-title":"Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies","volume":"140","author":"Rossi","year":"2020","journal-title":"Acta Neuropathol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40478-021-01175-w","article-title":"Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson's disease and dementia with Lewy bodies","volume":"9","author":"Bargar","year":"2021","journal-title":"Acta Neuropathol Commun"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s00702-023-02660-3","article-title":"Morphological characteristics differentiate dementia with Lewy bodies from Parkinson disease with and without dementia","volume":"130","author":"Jellinger","year":"2023","journal-title":"J Neural Transm (Vienna)"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/nan.12648","article-title":"Novel clinicopathological characteristics differentiate dementia with Lewy bodies from Parkinson\u2019s disease dementia","volume":"47","author":"Hansen","year":"2021","journal-title":"Neuropathol Appl Neurobiol"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40478-023-01714-7","article-title":"Prevalence, distribution, and severity of cerebral amyloid angiopathy differ between Lewy body diseases and Alzheimer\u2019s disease","volume":"12","author":"Walker","year":"2024","journal-title":"Acta Neuropathol Commun"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1093\/brain\/awae203","article-title":"Clinical and diagnostic implications of Alzheimer's disease copathology in Lewy body disease","volume":"147","author":"Barba","year":"2024","journal-title":"Brain"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1212\/WNL.0000000000003512","article-title":"Autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB","volume":"88","author":"Thomas","year":"2017","journal-title":"Neurology"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1555175\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T05:22:25Z","timestamp":1741843345000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1555175\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":53,"alternative-id":["10.3389\/fneur.2025.1555175"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2025.1555175","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,13]]},"article-number":"1555175"}}